These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 9734608

  • 1. IgA induced activation of human mesangial cells: independent of FcalphaR1 (CD 89).
    Diven SC, Caflisch CR, Hammond DK, Weigel PH, Oka JA, Goldblum RM.
    Kidney Int; 1998 Sep; 54(3):837-47. PubMed ID: 9734608
    [Abstract] [Full Text] [Related]

  • 2. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
    Wang Y, Zhao MH, Zhang YK, Li XM, Wang HY.
    Clin Exp Immunol; 2004 Apr; 136(1):168-75. PubMed ID: 15030528
    [Abstract] [Full Text] [Related]

  • 3. Identification of a novel Fcalpha receptor expressed by human mesangial cells.
    Barratt J, Greer MR, Pawluczyk IZ, Allen AC, Bailey EM, Buck KS, Feehally J.
    Kidney Int; 2000 May; 57(5):1936-48. PubMed ID: 10792612
    [Abstract] [Full Text] [Related]

  • 4. Increased binding of polymeric lambda-IgA to cultured human mesangial cells in IgA nephropathy.
    Lai KN, To WY, Li PK, Leung JC.
    Kidney Int; 1996 Mar; 49(3):839-45. PubMed ID: 8648928
    [Abstract] [Full Text] [Related]

  • 5. Charge-dependent binding of polymeric IgA1 to human mesangial cells in IgA nephropathy.
    Leung JC, Tang SC, Lam MF, Chan TM, Lai KN.
    Kidney Int; 2001 Jan; 59(1):277-85. PubMed ID: 11135081
    [Abstract] [Full Text] [Related]

  • 6. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
    Moura IC, Arcos-Fajardo M, Gdoura A, Leroy V, Sadaka C, Mahlaoui N, Lepelletier Y, Vrtovsnik F, Haddad E, Benhamou M, Monteiro RC.
    J Am Soc Nephrol; 2005 Sep; 16(9):2667-76. PubMed ID: 15987753
    [Abstract] [Full Text] [Related]

  • 7. Interactions of human mesangial cells with IgA and IgA-containing immune complexes.
    Novak J, Vu HL, Novak L, Julian BA, Mestecky J, Tomana M.
    Kidney Int; 2002 Aug; 62(2):465-75. PubMed ID: 12110007
    [Abstract] [Full Text] [Related]

  • 8. Differential binding characteristics of native monomeric and polymeric immunoglobulin A1 (IgA1) on human mesangial cells and the influence of in vitro deglycosylation of IgA1 molecules.
    Gao YH, Xu LX, Zhang JJ, Zhang Y, Zhao MH, Wang HY.
    Clin Exp Immunol; 2007 Jun; 148(3):507-14. PubMed ID: 17386074
    [Abstract] [Full Text] [Related]

  • 9. Mesangial Deposition Can Strongly Involve Innate-Like IgA Molecules Lacking Affinity Maturation.
    Wehbi B, Oblet C, Boyer F, Huard A, Druilhe A, Paraf F, Cogné E, Moreau J, El Makhour Y, Badran B, Van Egmond M, Cogné M, Aldigier JC.
    J Am Soc Nephrol; 2019 Jul; 30(7):1238-1249. PubMed ID: 31227634
    [Abstract] [Full Text] [Related]

  • 10. Activation of tubular epithelial cells by mesangial-derived TNF-alpha: glomerulotubular communication in IgA nephropathy.
    Chan LY, Leung JC, Tsang AW, Tang SC, Lai KN.
    Kidney Int; 2005 Feb; 67(2):602-12. PubMed ID: 15673307
    [Abstract] [Full Text] [Related]

  • 11. Medium from mesangial cells incubated with aggregated IgA1 from IgA nephropathy patients reduces podocyte adhesion through activation of the renin angiotensin system.
    Wang C, Liu X, Tang Y, Peng H, Ye Z, Zhang J, Tang H, Lou T.
    Swiss Med Wkly; 2011 Feb; 141():w13304. PubMed ID: 22252673
    [Abstract] [Full Text] [Related]

  • 12. Absence of CD89, polymeric immunoglobulin receptor, and asialoglycoprotein receptor on human mesangial cells.
    Leung JCK, Tsang AWL, Chan DTM, Lai KN.
    J Am Soc Nephrol; 2000 Feb; 11(2):241-249. PubMed ID: 10665931
    [Abstract] [Full Text] [Related]

  • 13. Mesangial expression of angiotensin II receptor in IgA nephropathy and its regulation by polymeric IgA1.
    Lai KN, Chan LY, Tang SC, Tsang AW, Li FF, Lam MF, Lui SL, Leung JC.
    Kidney Int; 2004 Oct; 66(4):1403-16. PubMed ID: 15458433
    [Abstract] [Full Text] [Related]

  • 14. Serum IgA1 from patients with IgA nephropathy up-regulates integrin-linked kinase synthesis and inhibits adhesive capacity in podocytes through indirect pathways.
    Ye ZC, Wang C, Tang Y, Liu X, Peng H, Zhang H, Lou TQ.
    Clin Invest Med; 2009 Feb 01; 32(1):E20-7. PubMed ID: 19178875
    [Abstract] [Full Text] [Related]

  • 15. Histone deacetylase inhibitors attenuate P-aIgA1-induced cell proliferation and extracellular matrix synthesis in human renal mesangial cells in vitro.
    Dai Q, Liu J, Du YL, Hao X, Ying J, Tan Y, He LQ, Wang WM, Chen N.
    Acta Pharmacol Sin; 2016 Feb 01; 37(2):228-34. PubMed ID: 26775659
    [Abstract] [Full Text] [Related]

  • 16. Injection of recombinant FcalphaRI/CD89 in mice does not induce mesangial IgA deposition.
    van der Boog PJ, van Kooten C, van Zandbergen G, Klar-Mohamad N, Oortwijn B, Bos NA, van Remoortere A, Hokke CH, de Fijter JW, Daha MR.
    Nephrol Dial Transplant; 2004 Nov 01; 19(11):2729-36. PubMed ID: 15340093
    [Abstract] [Full Text] [Related]

  • 17. [Serum IgA(1) from patients with IgA nephropathy induces phosphorylation of extracellular signal-regulated kinase and proliferation of human mesangial cells].
    Wang Y, Zhao M, Zhang Y, Li X, Wang H.
    Zhonghua Yi Xue Za Zhi; 2002 Oct 25; 82(20):1406-9. PubMed ID: 12509924
    [Abstract] [Full Text] [Related]

  • 18. Effect of aggregated immunoglobulin A1 from immunoglobulin A nephropathy patients on nephrin expression in podocytes.
    Wang C, Ye Z, Peng H, Tang H, Liu X, Chen Z, Yu X, Lou T.
    Nephrology (Carlton); 2009 Apr 25; 14(2):213-8. PubMed ID: 19019169
    [Abstract] [Full Text] [Related]

  • 19. Rapamycin Induces Autophagy and Reduces the Apoptosis of Podocytes Under a Stimulated Condition of Immunoglobulin A Nephropathy.
    Liang S, Jin J, Lin B, Gong J, Li Y, He Q.
    Kidney Blood Press Res; 2017 Apr 25; 42(1):177-187. PubMed ID: 28427080
    [Abstract] [Full Text] [Related]

  • 20. Transglutaminase is essential for IgA nephropathy development acting through IgA receptors.
    Berthelot L, Papista C, Maciel TT, Biarnes-Pelicot M, Tissandie E, Wang PH, Tamouza H, Jamin A, Bex-Coudrat J, Gestin A, Boumediene A, Arcos-Fajardo M, England P, Pillebout E, Walker F, Daugas E, Vrtosvnik F, Flamant M, Benhamou M, Cogné M, Moura IC, Monteiro RC.
    J Exp Med; 2012 Apr 09; 209(4):793-806. PubMed ID: 22451718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.